CORMEDIX INC (CRMD)
US21900C3088 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -50.24M | -46.34M | -29.70M | -28.21M | -22.03M | |||
| Depreciation Amortization | 72.59K | 70.76K | 80.00K | 60.00K | 130.00K | |||
| Change In Working Capital | -1.03M | 2.23M | 1.07M | 1.84M | -2.63M | |||
| Interest Paid | 34.14K | 34.30K | 30.00K | 20.00K | 30.00K | |||
| Other non cash items | 5.86M | 5.63M | 4.19M | 5.16M | 2.56M | |||
| OPERATING CASH FLOW | -45.33M | -38.41M | -24.36M | -21.16M | -21.97M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -378.61K | -327.30K | -220.00K | -1.43M | -110.00K | |||
| Other Investing Activity | 6.94M | -16.73M | -3.49M | -7.71M | 7.54M | |||
| INVESTING CASH FLOW | 6.57M | -17.06M | -3.71M | -9.13M | 7.43M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 48.92M | 56.12M | 17.90M | 41.76M | 40.10M | |||
| Other Financing Activity | N/A | -198.44K | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 48.62M | 55.92M | 17.90M | 41.76M | 40.10M | |||
| Exchange Rate Effect | 2.00K | 2.81K | -10.00K | -10.00K | 10.00K | |||
| CHANGE IN CASH | 9.87M | 448.44K | -10.18M | 11.46M | 25.57M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -45.33M | -38.41M | -24.36M | -21.16M | -21.97M | |||
| Capital Expenditure | -378.61K | -327.30K | -220.00K | -1.43M | -110.00K | |||
| FREE CASH FLOW | -45.71M | -38.74M | -24.58M | -22.59M | -22.08M | |||
All data in USD